NYSE : BHC

Bausch Health Companies Inc.

$4.83 USD

-$0.1 (-2.03%)

Volume
1.11M
Average Volume
2.24M
Market Capitalization
$1.8B
P/E Ratio
-1.50
Dividend Yield
0.00%
Price Target
$8.50
Year High
$8.69
Year Low
$4.57
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.32
Company Overview

NYSE

Thomas J. Appio

Drug Manufacturers - Specialty & Generic

Healthcare

BHC

20300

CA

USD

15147446792

071734107

0000885590

Liquidity Metrics

-10.10

1.32

0.97

0.29

0.00

Sales & Valuation

$10.45B

0.17

-0.87

1.82

2.65

Profitability

$0.43

$159.75M

-11.27%

-8.72%

120.75%

-4.86%

P/E Metrics

-1.50

0.00

0.00

Analyst Price Target & Rating

$8.50

$16.00

$8.00

Sell

2/5

38 Analysts

-43.18%

Poll Results

About Bausch Health Companies Inc. (NYSE:BHC) Stock

Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment is dedicated to vision care, encompassing surgical instruments, consumer eye health products, and ophthalmic pharmaceuticals. Salix specializes in delivering gastroenterology-specific products exclusively within the United States. The International Rx division markets Solta products, ... a range of branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across diverse geographies including Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. Ortho Dermatologics focuses on dermatological products in the U.S., in addition to distributing Solta's medical aesthetic devices globally. Finally, the Diversified Products segment supplies pharmaceutical solutions for neurology and other therapeutic categories, as well as generic medications and dental products, all within the U.S. The company was formerly known as Valeant Pharmaceuticals International, Inc., officially changing its name to Bausch Health Companies Inc. in July 2018. Its corporate headquarters are located in Laval, Canada.

Bausch to stop glaucoma eye drop development after trial miss

2026-07-09 17:12:43

Bausch + Lomb said on Thursday its glaucoma eye drop had missed ​the main goal in a mid-stage ‌trial of replicating visual function improvements observed in a smaller study.

Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026

2026-07-07 07:00:00

LAVAL, QC, July 7, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2026 financial results after market close on Wednesday, July 29, 2026. Bausch Health will host a live conference call and webcast at 5:00 p.m.

Michael Goettler Resigns from Bausch Health's Board of Directors

2026-07-01 16:15:00

LAVAL, QC, July 1, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that Michael Goettler has resigned from its Board of Directors, effective June 30, 2026, in connection with his appointment as President and Chief Executive Officer of Knoa Pharma LLC. "We thank Michael for his valued service and wish him the best in his new role," said John A.

Bausch (BHC) Down 5.4% Since Last Earnings Report: Can It Rebound?

2026-05-29 12:31:32

Bausch (BHC) reported earnings 30 days ago. What's next for the stock?

Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China

2026-05-28 16:15:00

Thermage ® , a pioneer in non-invasive skin tightening,  was awarded the AAA Well-Known Trademark Certification, the highest recognition in China's domestic trademark evaluation system. LAVAL, QC, May 28, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and Solta Medical, a global leader in the medical aesthetics market, are proud to announce that their flagship brand, Thermage®, was awarded the prestigious AAA Well-Known Trademark Certification ("AAA") by the China Trademark Association (CTA), a renowned accreditation reserved for top-tier brands.

Bausch Health Companies Inc. (BHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

2026-05-20 16:20:57

Bausch Health Companies Inc. (BHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Bausch Health Announces 2026 Annual Meeting of Shareholder Results

2026-05-19 16:15:00

LAVAL, QC, May 19, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that shareholders elected all 10 director nominees at its 2026 Annual Meeting of Shareholders ("Annual Meeting") held on May 19, 2026, including Eiry W. Roberts, M.D.

Bausch Health Companies Inc. (BHC) Presents at Barclays 30th Annual Leveraged Finance Conference 2026 Transcript

2026-05-19 15:31:09

Bausch Health Companies Inc. (BHC) Presents at Barclays 30th Annual Leveraged Finance Conference 2026 Transcript

Frequently Asked Questions

What is the current Bausch Health Companies Inc. (BHC) stock price?

Bausch Health Companies Inc.(NYSE:BHC) stock price is $4.83 in the last trading session. During the trading session, BHC stock reached the peak price of $8.69 while $4.57 was the lowest point it dropped to. The percentage change in BHC stock occurred in the recent session was --2.03% while the dollar amount for the price change in BHC stock was -$0.1.

BHC's industry and sector of operation?

The NYSE listed BHC is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of BHC?

Garen Sarafian | Vice President & Head of Investor Relations
Mirza Dautbegovic | Executive Vice President & Chief Operating Officer
Jiny Kim | Senior Vice President of Solta Medical
Kathleen Fitzpatrick | Executive Vice President and Chief HR & Communications Officer
Jonathan Sadeh | Executive Vice President, Chief Medical Officer and Head of R&D

How many employees does BHC have?

Number of BHC employees currently stands at 20300. BHC operates from 2150 St. ElzEar Boulevard West, Laval, QC H7L 4A8, CA.

Link for BHC official website?

Official Website of BHC is: https://www.bauschhealth.com

How do I contact BHC?

BHC could be contacted at phone #15147446792 and can also be accessed through its website. BHC operates from 2150 St. ElzEar Boulevard West, Laval, QC H7L 4A8, CA.

How many shares of BHC are traded daily?

The average number of BHC shares traded daily for last 3 months was 2.24M.

What is the market cap of BHC currently?

The market value of BHC currently stands at $1.8B with its latest stock price at $4.83